Government Affairs
Refine search
Pharmaceutical
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has called for stronger action on rare diseases, warning that fragmented systems continue to hold back research, diagnosis and access to treatment. 8 June 2026
Pharmaceutical
Fewer new innovative medicines, and in fact with a delay of almost two years from their approval by the European Medicines Agency (EMA), are coming to Greece, as demonstrated by the Association of Pharmaceutical Companies of Greece (SFEE) in a press conference held to present two studies concerning Greek patients' access to new, innovative treatments. 1 June 2026
Pharmaceutical
The Pharmaceutical Research and Manufacturers of America has used National Cancer Research Month to argue that US cancer research leadership could weaken if pricing and reimbursement policies reduce incentives for drug development. 29 May 2026
Pharmaceutical
The European Parliament and European Union (EU) member states have reached a provisional agreement on the Critical Medicines Act (CMA), a major legislative initiative designed to strengthen medicine supply chains and reduce dependence on overseas manufacturing. 22 May 2026
Pharmaceutical
Jeffery Taubenberger, the acting director of the US National Institute of Allergy and Infectious Diseases (NIAID), has stepped down from the role, according to reports citing congressional Democrats and sources familiar with the matter. 22 May 2026
Biotechnology
A new national framework designed to strengthen the delivery of advanced therapy clinical trials across the UK has been launched by the Advanced Therapy Treatment Centre (ATTC) network, as the country seeks to reinforce its position in the fast-growing cell and gene therapy sector. 20 May 2026
Pharmaceutical
Northern Ireland’s life sciences industry is set to benefit from closer collaboration with the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), it was announced Wednesday. 14 May 2026
Pharmaceutical
India has once again been placed on the Priority Watch List in the 2026 Special 301 Report released by the Office of the United States Trade Representative (USTR). 13 May 2026
Pharmaceutical
The Wall Street Journal Editorial Board is once again raising concerns about the USA’s federal 340B drug pricing program – this time questioning whether the program is benefiting patients at all. 12 May 2026
Pharmaceutical
For the first time, Swedish pharma trade group Lif launched its own program track at Vitalis. Together with the Swedish Medical Products Agency, SweTrial and Swedish Medtech, the focus was on how Sweden can strengthen its position as an attractive clinical trial country. 11 May 2026
Biosimilars
Industry group Medicines for Europe has urged policymakers to strengthen support for biosimilar medicines, arguing that wider uptake could improve patient access to biologic therapies while reinforcing Europe’s pharmaceutical resilience. 7 May 2026
Pharmaceutical
The US Centers for Medicare & Medicaid Services (CMS) will provide eligible Medicare beneficiaries access to certain GLP-1 medications for $50 per month beginning July 1, 2026, through December 31, 2027. 7 May 2026
Pharmaceutical
As Europe strives to compete globally in life sciences, predictable and robust IP incentives will determine whether tomorrow’s breakthroughs are developed here or elsewhere, says the European Federation of Pharmaceutical Industries and Associations (EFPIA). 27 April 2026
Pharmaceutical
India’s Central Drugs Standard Control Organization (CDSCO) and Brazil’s National Health Surveillance Agency (ANVISA), have established a framework to align regulatory practices. 27 April 2026
Pharmaceutical
Among significant news last week, Denmark’s Novo Nordisk presented positive results for its sickle cell disease candidate etavopivat. Eli Lilly revealed an up to $7 billion deal to acquire Kelonia Therapeutics and its gene therapy KLN-1010. The US Centers for Medicaid and Medicare Services (CMS) has extended the GLP-1 Bridge program for obesity medicines as insurers hold back. US biopharma Grace Therapeutics suffered a setback as the US Food and Drug Administration (FDA) issued a complete response letter (CRL) on the company’s new drug application (NDA) for GTx-104, which is being developed for aneurysmal subarachnoid hemorrhage (aSAH). 26 April 2026
Pharmaceutical
German family-owned pharma major Boehringer Ingelheim’s Indian subsidiary and India’s National Institute of Pharmaceutical Education and Research (NIPER) have signed a five year memorandum of understanding (MoU) to advance pharmaceutical research, education, and innovation in eastern India. 25 April 2026
Biotechnology
Over the decades, Germany’s Bayer has played as big a part as any company in the discovery and development of innovative medicines to treat patients around the world. 24 April 2026
Pharmaceutical
The US government is set to bear the financial burden of covering blockbuster obesity medicines for Medicare beneficiaries, after private insurers balked at participating in a planned long-term payment model. 22 April 2026
Pharmaceutical
As US states debate new proposals to regulate prescription drug prices - such as prescription drug boards or referencing federal or foreign pricing - it’s critical to examine the real-world consequences of government-set prices. 22 April 2026
Pharmaceutical
Russia plans to increase public procurements of anti-cancer drugs that will be part of a new national project, which aims to ensure two-thirds of cancer patients survive five years or more after diagnosis with cancer by 2030, reports The Pharma Letter’s local correspondent. 20 April 2026
Pharmaceutical
The US Food and Drug Administration (FDA) has announced that Tracy Beth Høeg has been appointed acting director of the Center for Drug Evaluation and Research (CDER). 4 December 2025
Pharmaceutical
IDA Ireland has released a new whitepaper setting out how the country intends to strengthen its role as a global center for biopharmaceutical manufacturing. The report highlights stability, regulatory strength and a deep talent base as crucial advantages as companies navigate geopolitical shifts and rapid advances in technology. 4 December 2025
Pharmaceutical
The US Food and Drug Administration’s (FDA) director of its Center for Drug Evaluation and Research (CDER) is to retire at the end of the month in the latest departure from the agency. 3 December 2025
Pharmaceutical
The UK government has sealed a deal to give the USA zero tariffs on pharmaceutical products imported into the country, in return for the National Health Service (NHS) spending more on medicines. 1 December 2025
Pharmaceutical
The board of directors of the Greek pharma trade group SFEE last week presented to the leadership of the Ministry of Health the study carried out in cooperation with Deloitte on the subject “A Roadmap for Greece’s Pharmaceutical Policy.” 1 December 2025
Biotechnology
Important regulatory news last week included Otsuka gaining accelerated Food and Drug Administration approval for its Voyxact (sibeprenlimab) for immunoglobulin A nephrology, India’s Sun Pharma for its Unloxcyt and Swiss giant Novartis for its spinal muscular atrophy drug Itvisma. Also of note, the US Centers for Medicare and Medicaid reported savings achieved in a second round of price negotiations. 30 November 2025
Biotechnology
The UK BioIndustry Association (BIA) has welcomed key measures in yesterday’s Autumn Budget that that broadly support the growth of life science and biotech scale-ups, while flagging concerns over rising costs for laboratory space. 27 November 2025
Pharmaceutical
In a show of rare bipartisan agreement in the US Congress, lawmakers raised concerns over how the 340B program is driving up costs for patients, taxpayers and employers, and stressed the need for reforming the program, commented trade group Pharmaceuticals Research Manufacturers of America (PhRMA). 26 November 2025
Pharmaceutical
The Russian government will create a temporary list of innovative drugs – the drugs, that will be a subject of state procurements on a fast truck basis. 25 November 2025
Pharmaceutical
Australian drugmaker Mayne Pharma last week revealed it has been notified by USA-based Cosette Pharmaceuticals that it had received written notice from the Foreign Investment Review Board (FIRB) stating that the Treasurer has objected to the proposed Scheme. 24 November 2025
Pharmaceutical
The US-China Economic and Security Review Commission has presented its 2025 annual report to Congress in the USA. 19 November 2025
Pharmaceutical
A major British initiative is set to repurpose used nuclear materials, converting them into a consistent supply for innovative cancer treatments. The £9.9 million ($13 million) from the Innovate UK SMMIP, plus £8.9 million from industry, is backing the development of Targeted Alpha Therapies. 18 November 2025
Pharmaceutical
New government funding will help make the boldest ideas in UK life sciences a reality – from putting robots to work in factories making medicines, to turning spent nuclear fuel into the next generation of cancer therapies. 18 November 2025
Pharmaceutical
Industry has welcomed the recommendations of the Danish government's Taskforce for enhanced knowledge and technology transfer. 17 November 2025
Pharmaceutical
Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a $200 million world-class pharmaceutical and life sciences cluster earmarked for Newton, Christ Church. 17 November 2025
Pharmaceutical
Between the US government shutdown, crippling international tariffs, debilitating funding cuts to critical research, and the general policy whiplash in Washington DC, it's little wonder many US-based life sciences companies are opting to expand in a more stable environment. Basel Area Business & Innovation says the Basel area in Switzerland is poised to welcome them. 15 November 2025
Pharmaceutical
The pharma trade group the Association of the British Pharmaceutical Industry (ABPI) and the UK government have agreed to a further extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG). 14 November 2025
Pharmaceutical
Escalating US tariff and pricing reforms are pushing pharmaceutical companies to localize manufacturing and rethink their investment priorities, fueling a surge in outsourcing-led strategies and targeted acquisitions. 12 November 2025
Biotechnology
In a strategic push to transform India’s pharmaceutical and biotech landscape, the government recently outlined and invited applications for the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme, aimed at bolstering R&D capabilities, particularly in rare disease therapies, gene-based treatments, and precision medicine. 10 November 2025
Pharmaceutical
The Association of the British Pharmaceutical Industry has urged the UK government to use the upcoming Budget to address what it describes as a decade-long slide in life sciences investment and competitiveness. The trade group said foreign direct investment in the sector has fallen 58% since 2021, with pharmaceutical R&D spending down nearly £100 million ($128 million) in 2023. 10 November 2025
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze